The RPB International Research Collaborators Award promotes international collaborations through which collaborating researchers in the U.S. and outside the U.S. gain new knowledge and skills. These international collaborations have the potential to accelerate the development of treatments for blinding disorders, positively affecting large populations worldwide for years to come.
Under a reciprocal arrangement, a U.S.-based researcher will be funded to go for a period of time to an institution outside the U.S. to gain new knowledge and/or skills, and deepen collaborative relationships with researchers there that will be conducive to future research collaborations. In turn, the institution outside the U.S. will send a researcher for a period of time to the U.S. institution from which the U.S. researcher came. An extended stay in the other country is expected by each researcher or a member of each researcher’s lab. A fair amount of flexibility in how this expectation can be implemented will be allowed.
The collaboration should provide a synergistic benefit to each researcher and to the culminating project. The submission must spell out specific and cogent objectives to be accomplished by each of the collaborating researchers toward the fulfillment of two broad goals: (1) gaining new knowledge and skills; and (2) strengthening collaborations across international boundaries. Successful candidates will leverage the unique expertise of each researcher, whereby their collaboration creates a work product that is more than the sum of its parts.
The award is open to U.S.-based researchers — MD, PhD, MD/PhD or equivalent doctoral degree — with a primary appointment as an Assistant Professor through full Professor in any department from any institution of higher education in the U.S.
This award is available to researchers from any institution of higher education in the U.S. Only one nomination per department per school will be considered in this grant category.
Eligible Countries:
Sponsor Institute/Organizations: Research to Prevent Blindness
Sponsor Type: Corporate/Non-Profit
Address: 360 Lexington Avenue, 22nd Floor New York, NY 10017
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Dec 15, 2025
Dec 15, 2025
$75,000
Affiliation: Research to Prevent Blindness
Address: 360 Lexington Avenue, 22nd Floor New York, NY 10017
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.